Funded Tech Companies

Engimmune Therapeutics

Headquartered in Basel, Engimmune Therapeutics is venture-backed, with investment from Novo Ventures, Pureos Bioventures and private investors.

Company Overview

Company Name
Engimmune Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Undisclosed
Basel, Undisclosed
Switzerland
Phone
Undisclosed
Email Address

Company Background Information

Overview
Engimmune was co-founded in 2021 by Dr. Rodrigo Vazquez-Lombardi, Prof. Sai Reddy and Dr. Søren Mouritsen based on inventions by Dr. Vazquez-Lombardi, who serves as the company CSO, and Prof. Reddy, who serves on the Scientific Advisory Board.
Profile
Engimmune Therapeutics LinkedIn Company Profile
Social Media
Engimmune Therapeutics Company Twitter Account
Company News
Engimmune Therapeutics News
Facebook
Engimmune Therapeutics on Facebook
YouTube
Engimmune Therapeutics on YouTube
Last Transaction
5/3/2022

Financing History

Date
Type
Amount
Venture Equity
$15,500,000


Management Team

Title
Name
Email & Social
Chairman
Bent Jakobsen
  Bent Jakobsen LinkedIn Profile  Bent Jakobsen Twitter Account  Bent Jakobsen News  Bent Jakobsen on Facebook
Chief Executive Officer
Søren Mouritsen
  Søren Mouritsen LinkedIn Profile  Søren Mouritsen Twitter Account  Søren Mouritsen News  Søren Mouritsen on Facebook
Chief Scientific Officer
Rodrigo Vazquez-Lombardi
  Rodrigo Vazquez-Lombardi LinkedIn Profile  Rodrigo Vazquez-Lombardi Twitter Account  Rodrigo Vazquez-Lombardi News  Rodrigo Vazquez-Lombardi on Facebook
Co-Founder
Sai Reddy
  Sai Reddy LinkedIn Profile  Sai Reddy Twitter Account  Sai Reddy News  Sai Reddy on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Engim | Engin Sciences

 

Share this article

 


About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary